KMT2A and leukemia: Notably, HOXA9, one of the most important genes downstream of the MLL fusion oncoprotein [24], is reported to rewire gene regulatory networks by mediating the establishment of leukemia-specific enhancers [25], and the MLL fusion oncoprotein itself has the ability for enhancer binding [26].